Artificial intelligence (AI) is rapidly changing the field of genomics by helping researchers and healthcare professionals analyze large volumes of genetic data more efficiently. From genome sequencing and disease diagnosis to drug discovery and precision medicine, AI is creating new opportunities to understand diseases and develop more personalized healthcare solutions.
The global AI in genomics sector was valued at USD 1.67 billion in 2025 and is expected to reach USD 2.06 billion in 2026. By 2035, it is projected to reach USD 13.88 billion, expanding at a CAGR of 23.6% from 2026 to 2035.
How AI Is Changing Genomics
Genomic sequencing produces enormous amounts of complex data that can be difficult to analyze manually. AI technologies, particularly machine learning and deep learning, can identify patterns, genetic variations, and relationships within this information.
These capabilities are helping researchers better understand genetic diseases, identify biomarkers, predict disease risks, and support more accurate genomic interpretation. AI can also integrate genomic information with clinical and biological datasets, providing a broader understanding of individual health conditions.
AI and Precision Medicine
Precision medicine is one of the most promising applications of AI in genomics. Instead of applying the same treatment approach to every patient, precision medicine uses individual characteristics, including genetic information, to support more targeted healthcare decisions.
AI can analyze genetic variations to identify potential disease risks and understand how patients may respond differently to particular treatments. This can help researchers and healthcare professionals develop more personalized treatment strategies.
Supporting Drug Discovery
AI is also becoming an important tool in drug discovery and development. By analyzing genomic datasets, AI systems can help researchers identify disease-related genes, discover potential therapeutic targets, and understand biological mechanisms.
This can potentially reduce the time required for certain stages of drug development while helping researchers identify promising treatment opportunities.
Key Growth Opportunities
The growing adoption of next-generation sequencing (NGS) is creating significant opportunities for AI in genomics. NGS generates large datasets that require advanced analytical technologies, making AI particularly valuable for genomic interpretation.
The sector is also benefiting from increasing research and development, cross-industry collaborations, investments in biotechnology, and growing demand for personalized healthcare.
North America held a major share of the sector in 2025, supported by technological advancements, research capabilities, investments, and the presence of major companies. Meanwhile, Asia-Pacific is expected to experience the fastest growth, driven by expanding biotechnology activities, healthcare investments, and government support.
Download a Sample Report: https://www.towardshealthcare.com/download-sample/5046
Challenges and Future Outlook
Despite its potential, AI in genomics faces challenges related to data quality, standardization, privacy, security, regulatory compliance, and the interpretation of AI-generated results.
Going forward, improvements in AI algorithms, genomic databases, next-generation sequencing, and data-sharing frameworks could further expand applications across healthcare and biotechnology.
AI is moving genomics from massive datasets toward actionable insights, helping create a future where diagnosis, drug development, and treatment can become increasingly precise and personalized.
About Us
Healthcare WebWire is a part of Towards Healthcare Research & Consulting which is a global healthcare market research and consulting firm dedicated to helping businesses make informed decisions through reliable market intelligence and strategic insights. We serve pharmaceutical, biotechnology, medical device, AI in healthcare, cell and gene therapy, digital health, and life sciences organizations with in-depth market research, custom consulting, competitive analysis, and growth forecasts. Our team combines industry expertise with rigorous research to deliver clear, actionable insights that support market expansion, product strategy, investment decisions, and long-term business growth. From emerging innovations to established healthcare markets, we help organizations understand where the industry is today and where it’s headed tomorrow.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Visit Our Website: Towards Healthcare Research & Consulting – Expert Consulting Solutions & Research Reports
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium